Guttmann v. Nissin Foods (U.S.A.) COMPANY, INC.
Filing
53
ORDER GRANTING IN PART AND DENYING IN PART DEFENDANT'S MOTION TO DISMISS re 38 First MOTION to Dismiss filed by Nissin Foods (U.S.A.) COMPANY, INC. Deadlines re standing remain in place.. Signed by Judge Alsup on 7/15/15. (whalc1, COURT STAFF) (Filed on 7/15/2015)
1
2
3
4
5
6
IN THE UNITED STATES DISTRICT COURT
7
FOR THE NORTHERN DISTRICT OF CALIFORNIA
8
9
11
For the Northern District of California
United States District Court
10
VICTOR GUTTMANN, on behalf of
himself and all others similarly situated,
12
Plaintiff,
13
No. C 15-00567 WHA
v.
14
NISSIN FOODS (U.S.A.) COMPANY,
INC.,
15
ORDER GRANTING IN PART
AND DENYING IN PART
DEFENDANT’S MOTION
TO DISMISS
Defendant.
/
16
17
18
INTRODUCTION
In this putative class action involving instant noodles, defendant manufacturer moves to
19
dismiss the complaint pursuant to Rules 12(b)(1) and 12(b)(6). For the reasons stated herein,
20
defendant’s motion is GRANTED IN PART AND DENIED IN PART.
21
22
STATEMENT
Our plaintiff, Victor Guttmann, seeks to eradicate artificial trans-fat from food. Since
23
2008, Guttmann has purchased and consumed a variety of instant noodle products manufactured
24
and sold by defendant Nissin Foods (U.S.A.) Company, Inc. Nissin’s noodle products contained
25
partially-hydrogenated oil, a food additive derived from low-cost oils. The manufacturing
26
process for partially-hydrogenated oils produces artificial trans-fat with a chemical structure
27
different from most naturally-occurring fat. The chemical properties of artificial trans-fat give
28
partially-hydrogenated oil a longer shelf life as compared to other additives derived from
low-cost oils (Amd. Compl. ¶¶ 10–15, 58).
1
Guttmann’s complaint cites numerous studies that purportedly link the consumption of
2
artificial trans-fat to increased risk of certain medical conditions such as cardiovascular heart
3
disease, diabetes, breast, prostate, and colorectal cancer, Alzheimer’s disease, and organ damage.
4
In particular, the complaint alleges “[t]here is ‘no safe level’ of artificial trans fat intake” and
5
“any incremental increase in trans fat increases risk of [cardiovascular heart disease]” (id. ¶¶
6
16–56). The use of partially-hydrogenated oils is not required by law, and while this motion
7
was pending, the Food and Drug Administration issued a final determination that partially-
8
hydrogenated oils are no longer “generally recognized as safe.” 80 Fed. Reg. 34650 (June 17,
9
2015). Pursuant to that determination, manufacturers have three years to remove partiallyhydrogenated oils from their products.
11
For the Northern District of California
United States District Court
10
Although all of Nissin’s noodle products contained partially-hydrogenated oils (and
12
listed those oils among the ingredients of those products), the nutrition-facts panel on each of the
13
product labels included the indication “Trans Fat: 0g.” Additionally, five of those products
14
included icons on the front of the product labels that described the product as containing
15
“0g Trans Fat” (Def.’s Request for Judicial Notice, Exhs. 1–13).1
16
FDA regulations do not require trans-fat content to be declared in the nutrition-facts
17
panel on a product label; however, “[i]f the serving contains less than 0.5 gram[s of trans-fat],
18
the content, when declared, shall be expressed as zero.” 21 C.F.R. 101.9(c)(2)(ii).
19
Guttmann claims that he relied on the “0g Trans Fat” icon when purchasing the five
20
products so labeled, because he was seeking products “that did not negatively affect blood
21
cholesterol levels or the health of his cardiovascular system, and products made with natural,
22
healthy ingredients.” He also claims he assumed that all of Nissin’s noodle products were safe
23
24
1
25
26
27
28
In support of this motion, Nissin has requested judicial notice of the contents of the labels on the
products referenced but not thoroughly described in Guttman’s complaint. Documents that are appropriate for
judicial notice may be considered on a motion to dismiss if they are referred to in the complaint and the parties
do not dispute their authenticity. Knievel v. ESPN, 393 F.3d 1068, 1076 (9th Cir. 2005). The authenticity of the
product labels was established by Nissin’s vice president of marketing, and Guttmann does not dispute
authenticity (Chung Decl. ¶ 3). Guttmann’s complaint specifically alleges that he purchased the products to
which these labels were affixed within this jurisdiction (Amd. Compl. ¶ 2). Accordingly, the contents of the
product labels may be considered for the purpose of adjudicating this motion.
2
1
to consume. Guttmann’s complaint also includes a list of several products similar to Nissin’s
2
noodles that do not contain artificial trans-fat (Amd. Compl. ¶¶ 3, 76–84; Appendix B).
3
This is not Guttmann’s first foray into litigation regarding artificial trans-fat. Guttmann
4
has filed three prior lawsuits regarding artificial trans-fat and food labeling. Chacanaca v. The
5
Quaker Oats Company, No. 10-0502 (N.D. Cal.) (Judge Richard Seeborg); Eileen Peviani, et al.
6
v. Hostess Brands, Inc., No. 10-02303 (C.D. Cal.) (Judge Consuelo Marshall); Guttmann v. Ole
7
Mexican Foods, Inc., No. 14-04845 (N.D. Cal.) (Judge Haywood Gilliam).
8
9
two nation-wide classes, the particulars of which are not yet in play (Amd. Compl. ¶ 85).
Guttmann’s complaint alleges eight claims for relief: (1) the unfair prong of the California
11
For the Northern District of California
United States District Court
10
In February 2015, Guttmann commenced this action against Nissin and seeks to represent
Unfair Competition Law, California Business & Professions Code Sections 17200, et seq., (2)
12
nuisance under California Civil Code Sections 3749, et seq., (3) breach of the implied warranty
13
of merchantability, (4) the unlawful prong of the California Unfair Competition Law, (5) the
14
fraudulent prong of the California Unfair Competition Law, (6) the California False Advertising
15
Law, California Business & Professions Code Sections 17500, et seq., (7) California Consumer
16
Legal Remedies Act, California Civil Code Sections 1750, et seq., and (8) breach of the express
17
warranty that the noodles contained 0g trans-fat. Guttmann seeks, among other things,
18
restitution, disgorgement, punitive damages, injunctive relief, and attorney’s fees.
19
20
Nissin now moves to dismiss Guttmann’s complaint pursuant to Rules 12(b)(1) and
12(b)(6). This order follows full briefing and oral argument.
21
ANALYSIS
GUTTMANN’S MISLABELING CLAIMS.
22
1.
23
With respect to the labels, which pertain to claims four through eight, federal law provides
24
25
an extensive scheme governing labels on food products.
“Nutrient-content claims,” which are statements about the nutrient contents of a food
26
product outside of the nutrition-facts panel, are governed by Section 343(r) of Title 21 of the
27
United States Code. The FDA has promulgated regulations regarding nutrient-content claims.
28
21 C.F.R. 101.13. An “express” nutrient-content claim, which does not implicitly characterize
3
1
the level of the nutrient in the food, may be included on a product label, provided “it is not
2
false or misleading in any respect.” Id. at 101.13(i)(3). States are expressly preempted from
3
establishing requirements for food labeling that are inconsistent with those requirements.
4
21 U.S.C. 343-1(a)(1)(5).
5
On the other hand, “nutrition facts,” which are statements about nutrient contents in the
6
nutrition-facts panel, are governed by Section 343(q) of Title 21 of the United States Code. The
7
FDA has also promulgated regulations regarding nutrition facts. 21 C.F.R. 101.9. Specifically,
8
as noted above, regulation requires the use of a “rounded value” for nutrition facts relating to
9
trans-fat content: “If the serving contains less than 0.5 gram[s of trans-fat], the content, when
11
For the Northern District of California
United States District Court
10
declared, shall be expressed as zero.” 21 C.F.R. 101.9(c)(2)(ii).
Guttmann’s complaint alleges five California state-law claims based on Nissin’s use of the
12
“0g Trans Fat” icon on the front of Nissin’s product labels. Guttmann argues that his claims
13
based on Nissin’s labels are not preempted by federal regulation because the “0g Trans Fat”
14
nutrient-content claim is misleading.
15
This precise issue was addressed in Chacanaca v. Quaker Oats Co., 752 F. Supp. 2d 1111
16
(N.D. Cal. 2010) (Judge Richard Seeborg), one of Guttmann’s prior challenges to the use of
17
artificial trans-fat in food products. There, Judge Seeborg looked to FDA comments on a
18
separate regulatory provision regarding “reference” claims, which are nutrient-content claims
19
that compare the contents of one product to those of another. The FDA had been asked to
20
resolve a dispute as to whether reference claims were required to use “rounded” values or
21
“unrounded” values and determined, “because there is no nutritional difference between rounded
22
and unrounded values of a nutrient in a food, the agency does not see a need to specify which
23
value should be used in determining whether or not a food qualifies to make a nutrient content
24
claim.” 58 Fed. Reg. 44020-01 at 44024 (Aug. 18, 1993). Judge Seeborg reasoned that if the
25
FDA had decided there was “no nutritional difference” between the rounded and unrounded
26
values in the context of reference claims, use of the unrounded value could not be misleading
27
when used as an express nutrient-content claim. Because that label was not misleading, any
28
state-law claim based on that label would establish requirements that were inconsistent with
4
1
343(r) and its regulations. Such claims were expressly preempted by Section 343-1(a)(5). So
2
too here.
3
Our court of appeals reached the same conclusion in an unpublished decision, Carrea v.
addressed concerns that discrepancies between a nutrient-content claim on a product label and
6
a statement in the nutrition-facts panel would be confusing to consumers. The FDA adjusted its
7
requirements for product labels to avoid such discrepancies. 58 Fed. Reg. 44020, 44024–25
8
(Aug 18, 1993). To permit state-law claims based on a “0g Trans Fat” nutrient-content claim
9
while the FDA required trans-fat to be declared as zero in the nutrition-facts panel would compel
10
such a discrepancy, which would impose a burden relating to product labeling not identical to the
11
For the Northern District of California
Dreyer’s Grand Ice Cream, Inc., 475 F. Appx. 113, 115 (9th Cir. 2012). The FDA had
5
United States District Court
4
requirements of federal law, which was expressly preempted. Carrea, 475 F. Appx. at 115–16.
12
The decision in Reid v. Johnson & Johnson, 780 F.3d 952, 962–963 (9th Cir. 2015), is not
13
to the contrary. There, the product label at issue included a nutrient-content claim of “No Trans
14
Fat.” The state-law claims based on that nutrient-content claim were not preempted by federal
15
law because the FDA had issued two warning letters to manufacturers stating that “No Trans
16
Fat” and “trans fat-free” were both “unauthorized nutrient-content claims.” No such letter has
17
been issued regarding “0g Trans Fat.” Reid does not control.
18
Accordingly, Guttmann’s fourth through eighth claims, namely, for violations of the
19
fraudulent and unlawful prongs of the Unfair Competition Law, the False Advertising Law, the
20
Consumer Legal Remedies Act, and for breach of express warranty, are DISMISSED. Leave to
21
amend will not be allowed due to futility.
22
2.
GUTTMANN’S USE CLAIMS.
23
Apart from the mislabeling claims (held preempted above), Guttmann alleges that Nissin
24
violated California law by including such a poisonous ingredient as artificial trans-fat in its
25
noodles. This goes to use, not labeling, and is not preempted.
26
27
28
5
1
2
A.
Guttmann’s Claim Under the Unfair Competition Law, Unfair Prong.
Guttmann argues that Nissin’s use of artificial trans-fat in its noodle products constitutes
3
an unfair business practice under California’s Unfair Competition Law. Nissin contends that
4
Guttmann’s claim is preempted by federal law.
5
No decision has addressed whether the lawful use of a dangerous substance in a food
6
product can constitute an unfair business practice within the context of the Unfair Competition
7
Law. While California appellate courts are not completely settled on what constitutes an
8
“unfair” business practice, unfairness is generally determined by either the “balancing test” or
9
the “tethering test.” See Lozano v. AT & T Wireless Services, Inc., 504 F.3d 718, 736 (9th Cir.
2007). Unfairness under the balancing test “involves balancing the harm to the consumer against
11
For the Northern District of California
United States District Court
10
the utility of the defendant’s practice.” Id. at 735. Under the tethering test, “unfairness must be
12
tethered to some legislatively declared policy or proof of some actual or threatened impact on
13
competition.” Ibid. (citing Cel-Tech Communications v. Los Angeles Cellular Telephone Co.,
14
20 Cal. 4th 163, 186–87 (1999)). “[A] practice may be deemed unfair even if not specifically
15
proscribed by some other law.” Cel-Tech, 20 Cal. 4th at 180.
16
Here, Guttmann has plausibly alleged that Nissin’s conduct violates the Unfair
17
Competition Law under the balancing test. His complaint alleges in great detail the serious harm
18
artificial trans-fat poses to public health, including that it causes “inflammation and damage to
19
vital organs and an increased risk of heart disease, diabetes, cancer, and death.” He further
20
alleges that the only utility in the use of partially-hydrogenated oils, as opposed to oils that do
21
not contain artificial trans-fat, is that partially-hydrogenated oils are less expensive (Amd.
22
Compl. ¶¶ 71, 81, Appendix B). Accordingly, Guttmann has stated a claim under the unfair
23
prong of the Unfair Competition Law.
24
25
26
27
28
Nissin argues that Guttmann’s claim is preempted by federal law.
[A] plaintiff may not bring an action under the unfair competition law
if some other provision bars it. That other provision must actually bar
it, however, and not merely fail to allow it. In other words, courts
may not use the unfair competition law to condemn actions the
Legislature permits. Conversely, the Legislature’s mere failure to
prohibit an activity does not prevent a court from finding it unfair.
Plaintiffs may not “plead around” a “safe harbor,” but the safety must
be more than the absence of danger.
6
1
Cel-Tech, 20 Cal. 4th at 182. Until recently, certain partially-hydrogenated oils, namely
2
low euric acid rapeseed oil and menhaden oil, were expressly designated “generally recognized
3
as safe” by the FDA. See 21 C.F.R. 184.1555(c)(2), 184.1472(b). Nissin uses soybean oil and
4
cottonseed oil and does not argue that those regulations directly apply (Def.’s Request for
5
Judicial Notice, Exhs. 1–13). The FDA declined to prohibit or expressly permit the use of other
6
partially-hydrogenated oils and artificial trans-fat, until June 17, when it determined that no form
7
of partially-hydrogenated oil was “generally recognized as safe.” 80 Fed. Reg. 34650 (June 17,
8
2015). The FDA’s prior declination to issue a regulation pertaining to all artificial trans-fats did
9
not establish a safe harbor protecting use of that ingredient from the reach of California law. In
fact, the California legislature has prohibited the use of artificial trans-fat in restaurants, although
11
For the Northern District of California
United States District Court
10
that statute does not apply to packaged goods. See Cal. Health & Safety Code § 114377.
12
Guttmann has stated a plausible claim under the unfair prong of the Unfair Competition
13
Law, and Nissin has failed to show that claim is preempted by federal law. Accordingly,
14
Nission’s motion to dismiss that claim is DENIED.
15
16
B.
Guttmann’s Claim for Breach Implied Warranty of Merchantibility.
In every contract for the sale of goods there is an implied warranty of merchantability that
17
the goods are “fit for the ordinary purposes for which such goods are sold.” Cal. Com. Code
18
§ 2314(2)(c). Guttmann argues that because Nissin’s noodles contained artificial trans-fat, they
19
were “not fit for human consumption,” which is the ordinary purpose for which a food product is
20
sold (Amd. Compl. ¶ 111). No decision has addressed whether the use of a dangerous food
21
additive can render a product “not fit for human consumption” for the purposes of the implied
22
warranty of fitness under California law.
23
Nissin argues that Guttmann has not alleged the kind of injury that generally gives rise to a
24
claim for breach of the implied warranty of merchantability, but that goes to standing, which this
25
order does not address. For the purposes of Rule 12(b)(6), Guttmann’s complaint has plausibly
26
alleged that foods containing artificial trans-fat are not fit for human consumption, due to the
27
myriad medical conditions to which they are linked.
28
7
1
Nissin’s best authority on point, Hoyte v. Yum! Brands, Inc., 489 F. Supp. 2d 24, 28
2
(D.D.C. 2007) (Judge James Robertson), reached a similar conclusion. That decision did not
3
reach the question of whether the inclusion of artificial trans-fat in a food product could
4
constitute a breach of the implied warranty of fitness because the plaintiff therein had failed to
5
allege an injury. This order does not reach that issue.
6
7
8
9
Guttmann has adequately pled that Nissin’s noodles were not fit for human consumption,
so Nissin’s motion to dismiss that claim under Rule 12(b)(6) is DENIED.
C.
Guttmann’s Public Nuisance Claim.
“Anything which is injurious to health . . . so as to interfere with the comfortable
enjoyment of life or property” constitutes a nuisance under Section 3479 of the California Civil
11
For the Northern District of California
United States District Court
10
Code. A private person may maintain an action for public nuisance if the conduct at issue is
12
“specially injurious to himself,” but not otherwise. Such a special injury must be “of a character
13
different in kind — not merely in degree — from that suffered by the general public.” Institoris
14
v. City of Los Angeles, 210 Cal. App. 3d 10, 20 (1989).
15
Guttmann argues that Nissin’s use of artificial trans-fat in its noodle products interfered
16
with the public’s “right to a safe food supply” and that he has suffered a special injury in the
17
form of alleged health risks associated with consumption of those noodles. No decision applying
18
California law has found that interference with the general public’s right to a safe food supply by
19
selling products with unhealthy ingredients constituted a public nuisance. The only injuries to
20
the general public alleged herein are the risk of harm due to the consumption of artificial trans-
21
fats and the cost of purchasing Nissin’s noodle products. Guttmann has not alleged that he has
22
suffered an injury different in kind from those injuries.
23
Guttmann cites Birke v. Oakwood Worldwide, 169 Cal. App. 4th 1540, 1550 (2009), for the
24
contention that an injury “to the health and comfort of an individual[] is in its nature special and
25
peculiar and does not cause a damage which can properly be said to be common or public.”
26
Guttmann admits, however, that the injury contemplated in that decision was the aggravation of
27
the plaintiff’s asthma due to the alleged nuisance of second-hand smoke, which was a special
28
injury as compared to the general public’s increased risk of lung cancer. Similarly, in Ileto v.
8
1
Glock, Inc., 349 F.3d 1191 (9th Cir. 2003), Guttmann’s other authority on point, the plaintiffs
2
had suffered mental trauma and physical injuries as direct victims of gun violence. The plaintiffs
3
were permitted to bring a nuisance claim based on the defendant’s alleged recklessness in the
4
distribution and sale of firearms, because their injury was different in kind from the injury of
5
danger and fear suffered by the general public.
6
There is no allegation that Guttmann suffered a specific personal injury that is different in
7
kind from the increased risk of harm allegedly suffered by all consumers of Nissin’s noodles.
8
Accordingly, Guttmann’s public nuisance claim is DISMISSED.
9
STANDING.
Nissin has also argued that Guttmann lacks standing under Article III and the Unfair
11
For the Northern District of California
United States District Court
10
3.
Competition Law. The Court has ordered limited discovery as to the dates and quantities of
12
Nissin’s noodles that Guttmann purchased and consumed, the extent to which he was aware that
13
FDA regulation required trans-fat content less than 0.5 grams per serving to be declared as zero
14
in the nutrition-facts panel, and the extent to which he has been medically diagnosed with any of
15
the conditions that the complaint alleges are caused by the consumption of artificial trans-fat
16
(Dkt. No. 50). That issue will be held in abeyance pending the results of that limited discovery.
17
CONCLUSION
18
For the reasons stated above, defendant’s motion to dismiss is GRANTED IN PART AND
19
DENIED IN PART. Guttmann’s claims for violation of the unfair prong of the Unfair Competition
20
Law and breach of the implied warranty of merchantability survive; all other claims are
21
dismissed without leave to amend.
22
23
IT IS SO ORDERED.
24
25
Dated: July 15, 2015.
WILLIAM ALSUP
UNITED STATES DISTRICT JUDGE
26
27
28
9
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?